Hentapan, Angelita M.

HRN: 00-54-88  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/23/2026
METRONIDAZOLE 500MG (TAB)
06/23/2026
06/30/2026
PO
500 MG
Q8
AGE Amoeboases, DFS WS
Checking Initial Appropriateness 
06/24/2026
CO-AMOXICLAV 625MG (TAB)
06/24/2026
07/01/2026
PO
625mg
Tid
Cap Lr
Checking Initial Appropriateness 
06/26/2026
CEFTAZIDIME 1GM (VIAL)
06/26/2026
07/03/2026
IV
2c
Q12
CAP MR
Checking Initial Appropriateness 
06/26/2026
AZITHROMYCIN 500MG IV
06/26/2026
06/30/2026
IV
500mg
Od
Cap Mr
Checking Initial Appropriateness 
06/30/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
06/30/2026
07/04/2026
IV
1300mg
Q24hrs
Septic Encephalopathy
Remove - Pending Acceptance
06/30/2026
METRONIDAZOLE 500MG (TAB)
06/30/2026
07/03/2026
PO
750
Q8hrs
AGE, DF WS
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: